Cooperative Agreement 2014NSBXK011

The Quinault Indian Nation (Nation) received a $688,141 Cooperative Agreement award from the U.S. Department of Justice Bureau of Justice Statistics under the NICS Act Record Improvement Program (NARIP), CFDA 16.813. The 24-month project will allow the Nation to continue operations and staffing to screen court records and report qualifying convictions and protection orders to the National Instant Criminal Background Check System (NICS) database. This work aligns with NARIP's goal of making...

The National Institute of Justice (NIJ) awarded a $2,000,000 Cooperative Agreement grant under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838) to The Fredric Rieders Family Renaissance Foundation. The grant funds the establishment and operation of the Novel Psychoactive Substance Discovery, Education, and Reporting Institute (NPS DISCERN). The key objectives are to: 1) develop an open-access drug early warning system, 2) create analytical resources to assist...

This federal Project Grant award of $351,780.00 was provided by the U.S. Department of Agriculture Rural Business Cooperative Services under the Rural Energy for America Program (REAP) (CFDA 10.868). The grant will fund the development of renewable energy systems and energy efficiency improvements for IPR Solutions LLC, a minority-owned for-profit limited liability company located in Nogales, Arizona. The award has a period of performance from September 2024 to September 2026. The REAP program...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $591,842 to Rebel Medicine Inc. to develop a novel long-acting local anesthetic formulation that can extend pain relief for up to 7 days following surgery. The goal is to create a safer alternative to opioid-based medications for post-operative pain management, addressing the critical public health issue of opioid overdose and misuse. Rebel...

This $500,000 federal Project Grant award from the Department of Health and Human Services Indian Health Service (CFDA 93.933 - Demonstration Projects for Indian Health) will support the Native American Rehabilitation Association of the Northwest, Inc. (NARA) in addressing the opioid crisis in tribal communities in the Portland, Oregon metropolitan area. The project aims to develop and expand community cultural education and awareness activities focused on prevention, treatment, and recovery for...

The National Renderers Association, Inc. was awarded a $3,000,000 Cooperative Agreement under the U.S. Department of Agriculture's (USDA) Regional Agricultural Promotion Program (CFDA 10.618) on December 23, 2024. The purpose of the award is to conduct approved market development activities intended to foster expanded exports and market diversification for U.S. agricultural commodities and products. The funding will support the organization's efforts to develop, maintain, and expand diverse...

This Cooperative Agreement, awarded by the National Park Service's National Office (federal agency ID 1400|1443|VPNPSNO-A), is funded under the National Park Service Conservation, Protection, Outreach, and Education program (CFDA 15.954). The $10,409,074 grant awarded to Capital Concerts, Inc. (UEI T88TREB62VV3) on January 1, 2025 supports the production and televised delivery of Memorial Day and Independence Day celebratory programs featuring the National Symphony Orchestra from the West Lawn...

This Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) provides $400,000 in funding to the Center for Health Justice, Inc., a Los Angeles-based non-profit organization. The project, titled "Project RENEW," aims to expand trauma-informed substance use disorder (SUD) treatment, recovery, and reentry services for 18-35...

The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded Jacaranda Biosciences, Inc. a $304,762 SBIR Phase 1 Project Grant under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The funding will support the development of novel JBI compounds that function through the unfolded protein response (UPR) to prevent the ototoxicity and hearing loss caused by cisplatin chemotherapy treatment. The key objectives are to optimize the efficacy...

This federal Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $19,302,777 to Nirsum Laboratories, Inc. to accelerate the development of NRS-033 towards Phase 3 trials and FDA registration for the treatment of opioid use disorder (OUD). The key products and services to be delivered include late-stage chemistry, manufacturing, and controls (CMC) for the active pharmaceutical ingredient (API) and...